ConductScience.org, home

Paper39698259

Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders.

Saxena SK and 10 others. ACS Pharmacol Transl Sci, 2024. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders. Papers, record 39698259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39698259

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders.
PubMed
Journal
ACS Pharmacol Transl Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
3.42, provisional
iCite
Revised in PubMed
2025-09-25
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saxena SKShailendra Khttps://orcid.org/0000-0003-2856-4185
2Ansari SSaniya
3Maurya VKVimal K
4Kumar SSwatantra
5Sharma DDeepak
6Malhotra HSHardeep S
7Tiwari SSneham
8Srivastava CChhitij
9Paweska JTJanusz T
10Abdel-Moneim ASAhmed S
11Nityanand SSoniya

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References111

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122229116Neuropathological alterations in Alzheimer disease.Cold Spring Harb Perspect Med2011https://conductscience.org/library/papers/22229116PubMed
232303714Author Correction: Dynamics of oligomer populations formed during the aggregation of Alzheimer's Aβ42 peptide.Nat Chem2020https://conductscience.org/library/papers/32303714PubMed
325523424Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.Curr Alzheimer Res2015https://conductscience.org/library/papers/25523424PubMed
414687544Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.Neuron2003https://conductscience.org/library/papers/14687544PubMed
529481488Neprilysin in the Cerebrospinal Fluid and Serum of Patients Infected With HIV1-Subtypes C and B.J Acquir Immune Defic Syndr2018https://conductscience.org/library/papers/29481488PubMed
636523572Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019.Front Public Health2022https://conductscience.org/library/papers/36523572PubMed
73516994Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin.J Biol Chem1986https://conductscience.org/library/papers/3516994PubMed
817585404Neurological disorders affect millions globally.J Environ Health2007https://conductscience.org/library/papers/17585404PubMed
914749444Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain.J Neurosci2004https://conductscience.org/library/papers/14749444PubMed
1024391587Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease.Front Aging Neurosci2013https://conductscience.org/library/papers/24391587PubMed
1110676850What the evolution of the amyloid protein precursor supergene family tells us about its function.Neurochem Int2000https://conductscience.org/library/papers/10676850PubMed
1215293994Solution structure of amyloid beta-peptide (25-35) in different media.J Med Chem2004https://conductscience.org/library/papers/15293994PubMed
1319773363Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway.J Cell Sci2009https://conductscience.org/library/papers/19773363PubMed
1412972166Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.Neurosci Lett2003https://conductscience.org/library/papers/12972166PubMed
1515860464Mutation screening and association study of the neprilysin gene in sporadic Alzheimer's disease in Chinese persons.J Gerontol A Biol Sci Med Sci2005https://conductscience.org/library/papers/15860464PubMed
1615778722Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.Nat Med2005https://conductscience.org/library/papers/15778722PubMed
1712657655Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.J Neurosci2003https://conductscience.org/library/papers/12657655PubMed
1831266021Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease.Neurodegener Dis2019https://conductscience.org/library/papers/31266021PubMed
1911375493Metabolic regulation of brain Abeta by neprilysin.Science2001https://conductscience.org/library/papers/11375493PubMed
2034239348Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.Int J Biol Sci2021https://conductscience.org/library/papers/34239348PubMed

See all 111 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42633327Magnetoreceptive CRY/MagR complexes: linking circadian redox signalling to protein aggregation in Alzheimer's and Parkinson's disease.ADMET DMPK2026https://conductscience.org/library/papers/42633327PubMed
42438074Combating ageing beyond the cell: Emerging roles of extracellular proteostasis.FEBS J2026https://conductscience.org/library/papers/42438074PubMed
42237901The expanding role of protease therapeutics (2012-2026): from replacement therapies to immune system modulation and beyond.Biochem J2026https://conductscience.org/library/papers/42237901PubMed
42072660Mast Cells and Substance P: Neuroinflammatory Loops at the Molecular and Translational Clinical Levels.Biomolecules2026https://conductscience.org/library/papers/42072660PubMed
41834915Bridging pathologies: Mechanistic insights into the diabetes-Alzheimer's nexus.EXCLI J2026https://conductscience.org/library/papers/41834915PubMed
41683989From Traumatic Brain Injury to Alzheimer's Disease: Multilevel Biomechanical, Neurovascular, and Molecular Mechanisms with Emerging Therapeutic Directions.Int J Mol Sci2026https://conductscience.org/library/papers/41683989PubMed
41670689Intranasal CM-hMSCs modulate brain gene expression linked to glucose metabolism and inflammation in male and female rats exposed to maternal and post-weaning high-fat diets.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41670689PubMed
41589495Enzymatic Biomarkers for Early Diagnosis of Alzheimer's Disease: Uncovering Key Targets and Mechanisms.CNS Neurol Disord Drug Targets2026https://conductscience.org/library/papers/41589495PubMed
41014460Targeting the awry Aβ pathway in Alzheimer's disease: hype and hurdles.Inflammopharmacology2025https://conductscience.org/library/papers/41014460PubMed
41009633Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer's Disease and HIV-Associated Neurocognitive Disorders.Int J Mol Sci2025https://conductscience.org/library/papers/41009633PubMed
41007730Intrathecal Therapies for Neurodegenerative Diseases: A Review of Current Approaches and the Urgent Need for Advanced Delivery Systems.Biomedicines2025https://conductscience.org/library/papers/41007730PubMed
40627107Exosome-Mediated Delivery of Amyloid Beta Modulators: A Potential Therapeutic Strategy for Alzheimer's Disease.Mol Neurobiol2025https://conductscience.org/library/papers/40627107PubMed
40581884Neprilysin regulates the progression of glioblastoma: an in-vitro study using siRNA mediated gene silencing and HDAC1 mediated upregulation of neprilysin in U87 MG cells.Mol Cell Biochem2025https://conductscience.org/library/papers/40581884PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
KNG13827PubTator's text mininghttps://conductscience.org/library/genes/3827NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
MME4311PubTator's text mininghttps://conductscience.org/library/genes/4311NCBI Gene
TAC16863PubTator's text mininghttps://conductscience.org/library/genes/6863NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39698259

GET https://conductscience.org/api/papers/v1/39698259/references?page=2